Skip to content
LATEST
Health

Low Testosterone Levels Linked to 18% Increase in Cancer Mortality Risk

An international study of 26,000 men found that testosterone levels below 8.6 nmol/L are associated with an 18% higher risk of cancer mortality, though…

Low Testosterone Levels Linked to 18% Increase in Cancer Mortality Risk

A large-scale international study involving over 26,000 participants has identified a correlation between low testosterone levels and an 18% higher risk of cancer-related mortality. The research, which tracked hormone concentrations and health outcomes over several decades, suggests that testosterone levels below 8.6 nmol/L may serve as a significant biomarker for future health risks.

The study, which analyzed data from 11 long-term cohorts across Australia, the United States, and Europe, indicates that this increased mortality risk persists even when adjusting for age and other health-related variables. While the findings establish a statistical association, they do not confirm a causal relationship between low testosterone and the development of cancer.

United States

Notably, the research found no evidence linking natural testosterone levels to the development of prostate cancer. Instead, prostate cancer risk was more closely associated with low levels of sex hormone-binding globulin (SHBG) and luteinizing hormone. This distinction clarifies the differing roles of various sex hormones in male health outcomes.

Medical professionals caution that these findings do not support the use of testosterone supplementation as a preventative measure against cancer. There is currently no clinical evidence to suggest that increasing testosterone levels through external intervention reduces cancer risk. Instead, the study suggests that clinicians should view low testosterone as an early warning sign that warrants further investigation into a patient's overall health profile.

More stories

Latest news